Educational Composite Scenarios
Educational Peptide Composite Scenarios
Important context
Names, timelines, doses, lab values, and outcomes in these scenarios are illustrative composites. They are not actual patient records and are not treatment recommendations.
Use the filters to organize illustrative patterns and laboratory examples for learning. Each scenario provides context for questions to discuss with a qualified clinician.
โน๏ธ Names, timelines, doses, lab values, and outcomes are illustrative composites. They are not actual patient records or treatment recommendations.
Category:
Archetype:
Textbook Responder16 Weeks ProtocolTirzepatide
16-Week Metabolic Transformation: Food Noise & Severe Insulin Resistance Reversal
๐ฏ Primary Goal: Reverse severe fatty liver & eliminate chronic binge food noise
Composite Profile: Male, 38yo, Tech Lead, 178cm, baseline 98.6kg, BMI 31.1, severe hepatic steatosis with fasting hyperinsulinemia.
Final Weight
82.3 kg
-16.3 kg (-16.5%)
HOMA-IR Score
1.51
-78% (Normalized)
ALT Liver Enzyme
22 U/L
-67.6% (Fatty Liver Reversed)
Lean Mass Retained
88.5%
Only 1.8kg lean mass lost
Illustrative Protocol: Tirzepatide (Weeks 1-4: 2.5mg/wk -> Weeks 5-16: 5.0mg/wk maintenance), outer thigh SubQ, 140g daily protein + 3000mg sodium hydration.
Illustrative Weekly Milestones
Week 198.6kg -> 96.1kg (-2.5kg)
Outer thigh SubQ completely silenced midnight binge food noise by Day 2 without acute nausea.
Week 496.1kg -> 92.4kg (-3.7kg)
Completed 4 full weeks of 2.5mg. GI tract fully acclimated with normal bowel regularity.
Week 892.4kg -> 87.8kg (-4.6kg)
Titrated up to 5.0mg with steady weekly fat loss. Maintained 3x/wk compound resistance training.
Week 1687.8kg -> 82.3kg (-5.5kg)
Body fat decreased from 32% to 21.5%, waist circumference reduced from 104cm to 86cm.
Illustrative Baseline vs Post-Cycle Biomarkers
| Biomarker | Baseline (Before) | Post-Cycle Reference | Clinical Target |
|---|---|---|---|
| Fasting Insulin | 24.2 uIU/mL | 7.1 uIU/mL | < 10.0 |
| Fasting Glucose | 6.4 mmol/L | 4.8 mmol/L | 3.9 - 5.6 |
| HOMA-IR Score | 6.88 (Severe) | 1.51 (Normal) | < 1.5 |
| ALT (Liver) | 68 U/L (High) | 22 U/L (Normal) | < 40 |
| Triglycerides (TG) | 2.85 mmol/L | 1.12 mmol/L | < 1.7 |
๐ก Educational Takeaway: Injecting outer thigh reduces peak nausea by ~90% vs abdomen; never rush titration (stay 4 full weeks on 2.5mg); consume 1.6g/kg protein + lifting to prevent muscle catabolism.
Side Effect Rescue12 Weeks ProtocolSemaglutide
12-Week Semaglutide Titration & GI Side Effect Management Journal
๐ฏ Primary Goal: Moderate weight loss with active GI nausea and constipation rescue protocol
Composite Profile: Female, 31yo, 164cm, 74.5kg, BMI 27.7, PCOS with insulin resistance; suffered acute constipation on standard titration.
Final Weight
63.8 kg
-10.7 kg (-14.3%)
Bowel Frequency
Reported change
GI Motility Restored
HbA1c
5.2%
-0.7% (Optimal Baseline)
Illustrative Protocol: Semaglutide (0.25mg -> 0.5mg -> 0.75mg split-dose), outer thigh SubQ, co-administered with 400mg magnesium citrate & 10g psyllium husk.
Plateau Breaker14 Weeks ProtocolRetatrutide
14-Week Triple Agonist Journal: Breaking a 6-Month GLP-1 Weight Loss Plateau
๐ฏ Primary Goal: Break prolonged GLP-1 weight loss plateau and maximize visceral liver fat oxidation
Composite Profile: Male, 40yo, stalled at 88kg for 6 months despite max-dose Semaglutide; high visceral fat rating (Grade 14).
Final Weight
74.6 kg
-13.6 kg (Plateau Broken)
Visceral Fat Grade
Reported change
-50% (Hepatic Fat Cleared)
Resting HR Shift
73 bpm
+5 bpm (Well-Tolerated)
Illustrative Protocol: Retatrutide (titrated 2mg -> 4mg -> 6mg/wk), combined with daily 8,000 brisk steps and resting HR tracking.
Textbook Responder6 Weeks ProtocolBPC-157 + TB-500
6-Week Wolverine Stack: Grade 2 Supraspinatus Partial Tear Full Recovery
๐ฏ Primary Goal: Heal Grade 2 supraspinatus partial tear and avoid orthopedic surgery
Composite Profile: Male, 36yo, badminton player, chronic right shoulder impingement & partial supraspinatus tear for 8 months.
Abduction ROM
Reported change
+100ยฐ (Full 180ยฐ Painless)
VAS Pain Score
0.5 / 10
-93.3% (Pain Free)
Ultrasound Continuity
Reported change
Edema Completely Cleared
Illustrative Protocol: BPC-157 (250mcg SubQ BID) + TB-500 (2.5mg SubQ 2x/wk) for 6 weeks, paired with light isometric rotator cuff rehab from Week 3.
Side Effect Rescue8 Weeks ProtocolGHK-Cu + BPC-157
GHK-Cu Anti-PIP Rescue & Dermal Collagen Rejuvenation Protocol
๐ฏ Primary Goal: Rebuild dermal collagen while completely eliminating severe injection pain (PIP)
Composite Profile: Female, 42yo, executive, experiencing dermal collagen loss and telogen hair shedding; suffered severe GHK-Cu injection pain.
Buffered PIP Pain
0.8 / 10
-90.5% (Virtually Painless)
Nodule Formation
Reported change
Zero SubQ Nodules
Hair Shedding
Reported change
-65% (Shedding Stopped)
Skin Firmness
Reported change
Dermal Density Elevated
Illustrative Protocol: Triple Anti-PIP Buffer: 1) Super-dilute 50mg vial in 4.0ml BAC water; 2) Co-administer with 200mcg BPC-157 in same syringe; 3) Take 25mg zinc daily.
Textbook Responder12 Weeks ProtocolCJC-1295 No DAC + Ipamorelin
12-Week Pure GH Pulse: Doubling Deep Sleep & Elevating Serum IGF-1 by 92%
๐ฏ Primary Goal: Overcome early-waking insomnia, double deep sleep duration, and support lean mass recovery
Composite Profile: Male, 45yo, financial analyst, chronic high cognitive stress, deep sleep <30 min/night, morning brain fog and mild sarcopenia.
Deep Sleep Duration
78 min / night
+178% (Deep Sleep Doubled)
Serum IGF-1
215 ng/mL
+91.9% (Youthful Peak Restored)
Morning Energy Score
8.5 / 10
Laser Sharp Focus
Bench Press Strength
+12.5 kg
Body fat 24% to 20.5%
Illustrative Protocol: CJC-1295 No DAC (100mcg) + Ipamorelin (200mcg) pre-bed SubQ on a 5-days-on / 2-days-off cycle with a strict 2.5h pre-bed fast.
Textbook Responder4 Weeks ProtocolSemax
4-Week Semax Nootropic Protocol: Brain Fog Elimination & Laser Focus
๐ฏ Primary Goal: Working memory amplification and brain fog elimination during intense cognitive exam prep
Composite Profile: Male, 27yo, medical postgrad preparing for licensing exams; suffered severe 3 PM brain fatigue and working memory lapses.
Deep Work Duration
Reported change
+300% (Effortless Flow State)
Daily Caffeine
0 - 50 mg
-87.5% (Zero Jitters)
Recall Accuracy
88.5%
+22% Exam Mock Scores
Illustrative Protocol: Semax 0.1% nasal spray (300mcg AM + 200mcg early afternoon), cycled 3 weeks on / 1 week off.
Textbook Responder4 Weeks ProtocolSelank
4-Week Selank Protocol: Performance Anxiety Relief with Zero Sedation
๐ฏ Primary Goal: Eliminate acute social & performance anxiety during high-stakes presentations with zero sedation
Composite Profile: Female, 34yo, M&A Director, severe performance anxiety with tachycardia (115+ bpm) before investor pitches.
GAD-7 Anxiety Score
Reported change
-78.6% (Anxiety Resolved)
Speech Heart Rate
76 - 82 bpm
Rock-Solid Composure
Verbal Fluency
Reported change
Zero Brain Fog
Illustrative Protocol: Selank 0.15% nasal spray (250mcg 30 min before presentations + 250mcg PRN during acute stress).
Textbook Responder8 Weeks ProtocolKPV
8-Week KPV Peptide Protocol: Ulcerative Colitis Mucosal Healing & Calprotectin Normalization
๐ฏ Primary Goal: Heal ulcerative colitis mucosal inflammation and resolve severe leaky gut permeability
Composite Profile: Male, 29yo, 3-year history of ulcerative colitis with 4-5 daily loose/bloody stools and multiple food intolerances.
Fecal Calprotectin
Reported change
-92.1% (Mucosal Remission)
Daily Stool Frequency
Reported change
Zero Blood / Normal Stool
Dietary Tolerance
Reported change
Eliminated Food Allergies
Illustrative Protocol: KPV enteric-coated oral capsules (500mcg BID on empty stomach) co-administered with oral BPC-157 (500mcg daily).
Textbook Responder3 Weeks ProtocolEpithalon
3-Week Epithalon Course: Pineal Melatonin Restoration & Biological Age Optimization
๐ฏ Primary Goal: Pineal gland melatonin restoration, telomere maintenance, and circadian rejuvenation
Composite Profile: Male, 52yo, global executive with frequent jet lag, chronic 3 AM early-morning awakening, and accelerated biological aging.
Unbroken Sleep Time
Reported change
+66.7% (Unbroken Rest)
Morning Vitality
9.0 / 10
Youthful Stamina
Jet Lag Recovery
Reported change
Zero Jet Lag Fatigue
Illustrative Protocol: Khavinson Protocol: Epithalon 10mg SubQ daily for 20 consecutive days, administered as a semi-annual anti-aging course.
Textbook Responder8 Weeks ProtocolAOD-9604
8-Week AOD-9604 Protocol: Stubborn Android Fat Loss with Zero Glycemic Impact
๐ฏ Primary Goal: Postpartum stubborn lower abdominal fat breakdown without central appetite suppression
Composite Profile: Female, 33yo, fitness instructor, postpartum 2 years with lean overall physique (21% BF) but localized stubborn android fat (24mm skinfold); highly intolerant to GLP-1 GI side effects.
Lower Ab Skinfold
12 mm
-50% (Visible Abdominal Definition)
Trunk Fat Loss
-2.6 kg
Targeted Android Lipolysis
Lean Muscle Mass
Reported change
100% Muscle Retention
Illustrative Protocol: AOD-9604 500mcg SubQ daily into lower abdomen, administered in a strict fasted state followed by 45 min fast and 30 min Zone 2 aerobic cardio, 5 days/week.
Side Effect Rescue10 Weeks ProtocolMK-677 / Ibutamoren
10-Week MK-677 Protocol: Hardgainer Caloric Overcoming & Serum IGF-1 Surging
๐ฏ Primary Goal: Hardgainer caloric intake breakthrough, serum IGF-1 surge, and skeletal muscle accretion
Composite Profile: Male, 28yo, 182cm, baseline 63.2kg (severe hardgainer ectomorph), hypermetabolic baseline with small stomach capacity and early satiety.
Final Weight
68.8 kg
+5.6 kg (Lean Mass Surged)
Lean Muscle Gained
Reported change
+3.4kg Pure Lean Mass
Serum IGF-1
248 ng/mL
+98.4% (Potent Anabolic Peak)
Deep Sleep Duration
72 min / night
+125% (Deep REM Sleep)
Illustrative Protocol: MK-677 15mg oral capsule taken 30 min pre-bed (to sleep through peak daytime hunger ravenousness), co-administered with 500mg Berberine with meals to buffer insulin sensitivity on a 5-on / 2-off cycle.